The short answer
Small studies report lipid changes, but independent replication and standardized products are limited.
- Evidence and scope
- Emerging evidence
This status does not grade the ingredient for every goal, outcome, or person.
- Important limitation
- Early human findings are hypothesis-generating; efficacy, long-term safety, and optimal dose remain uncertain.
- Before deciding
- Key concern: Statins, CYP3A4 medicines, photosensitivity, liver disease, and pregnancy require review.
01 / PRACTICAL GUIDE
Dose, absorption, and combinations
These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.
Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.
Dose source ↗More is not automatically better. A clinician or product label may specify a different amount.
Not usefully classified as a fat- or water-soluble vitamin; absorption depends on the salt, extract, delivery system, and meal.
Take with meals according to the studied product.
Statins, CYP3A4 medicines, photosensitivity, liver disease, and pregnancy require review.
Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.
02 / EVIDENCE
What the research says
We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.
These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.
Open the research timelineResearch timeline+
Entries are ordered by publication year. A study period appears only when the source reports it.
Bergamot supplementation and lipid profiles
Large pooled lipid changes favored bergamot, but the authors also described results across bergamot nutraceuticals as inconsistent. Product mixtures, extract standardization, and absent pooled participant reporting make the magnitude uncertain and do not establish cardiovascular outcomes.
Study design and methods
- Design
- Systematic review and meta-analysis of 14 trials
- Population
- Adults receiving oral bergamot products; the abstract did not report a participant total
- Intervention
- Bergamot supplements and bergamot-containing nutraceuticals
- Outcome
- Total, LDL, and HDL cholesterol and triglycerides
Unscreened discovery appendix—not evidence0 candidate publicationsSearch run: Aug 21, 2026
Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.
03 / SOURCES
Start with the source material
The live search is for discovery only. Search-result counts change and are not included in the audited totals above.
04 / EXPERT CONTEXT
Expert context—not evidence
Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.
No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.